Lot-to-Lot Consistency, Bridging, and Safety Trial of ChimeriVax -Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines.

Trial Profile

Lot-to-Lot Consistency, Bridging, and Safety Trial of ChimeriVax -Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Apr 2015

At a glance

  • Drugs Japanese encephalitis vaccine (Primary) ; Hepatitis A vaccine inactivated
  • Indications Hepatitis A; Japanese encephalitis
  • Focus Pharmacodynamics; Registrational
  • Sponsors Sanofi; sanofi pasteur
  • Most Recent Events

    • 14 Aug 2014 According to ClinicalTrials.gov record, additional secondary endpoints added.
    • 28 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 28 Oct 2009 Actual patient number (1199) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top